Scientists are testing a new drug in the hope that it could slow down the condition
Researchers are looking for people with early stage Parkinson’s to take part in a global research study evaluating whether an new medication can slow the progression of Parkinson’s over time.
Sponsored by biopharma company UCB, the Orchestra Study is a Phase II trial investigating the effects, safety and tolerability of a compound currently known as UCB0599.
The researchers need people who*:
*There are additional criteria which the study team will assess and discuss with potential participants.
To find out more about the study and to see if you are eligible to take part, visit the Orchestra Research Study Trial website. Taking part in research is entirely voluntary and participants may leave the study at any time.
As well as contributing to Parkinson’s research, taking part will give you access to healthcare professionals who can help you gain more knowledge about your condition.
How do you feel about taking part in clinical trials? Email [email protected] and tell us your thoughts.
Parkinson's Europe is sharing this article for information purposes only; it does not represent Parkinson's Europe's views and is not an endorsement by Parkinson's Europe of any particular treatments, therapies or products.